Inhibrx Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022
Market Capitalization	196	-	-
Enterprise Value	199	3	5
EV/Sales Ratio	-	1.94	3.83
EV/EBITDA Ratio	-	-0.02	-0.04
EV/EBIT Ratio	-	-0.02	-0.04
EV/FCF Ratio	-	-0.02	-0.06
Debt / Equity Ratio	-0.25	-0.40	-0.69
Debt / EBITDA Ratio	-	-0.02	-0.04
Debt / FCF Ratio	-	-0.02	-0.06
Quick Ratio	0.01	0.02	0.01
Current Ratio	0.37	0.41	0.30
Asset Turnover	-	0.08	-
Return on Equity (ROE)	-	2029.30%	-
Return on Assets (ROA)	-	-726.80%	-
Return on Capital (ROIC)	-	3182.23%	5087.03%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).